Status:

COMPLETED

Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) - Outcome Study of Cryotherapy for Retinopathy of Prematurity

Lead Sponsor:

National Eye Institute (NEI)

Conditions:

Retinopathy of Prematurity

Eligibility:

All Genders

Up to 1 years

Phase:

NA

Brief Summary

To determine the safety and efficacy of trans-scleral cryotherapy of the peripheral retina in certain low birth-weight infants with retinopathy of prematurity (ROP) for reducing blindness from ROP. T...

Detailed Description

ROP is a disease of the eyes of prematurely born infants in which the retinal blood vessels increase in number and branch excessively, sometimes leading to hemorrhage or scarring. Before the establish...

Eligibility Criteria

Inclusion

  • Premature infants of either gender who were eligible for the natural history study had weighed less than 1,251 grams at birth and had survived the first 28 days of life. They had no major ocular or systemic congenital anomalies. Infants who met these criteria and also had a threshold level of ROP (defined as stage 3+ of the International Classification of Retinopathy of Prematurity occupying five or more contiguous or eight cumulative 30 degree sectors \[clock hours\] of stage 3 ROP in zone I or II in the presence of plus disease) could be referred for examination to determine eligibility for entry to the cryotherapy trial.

Exclusion

    Key Trial Info

    Start Date :

    January 1 1986

    Trial Type :

    INTERVENTIONAL

    End Date :

    August 1 2003

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00000133

    Start Date

    January 1 1986

    End Date

    August 1 2003

    Last Update

    February 4 2014

    Active Locations (24)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 6 (24 locations)

    1

    Alabama Ophthalmology Associates, P.C.

    Birmingham, Alabama, United States

    2

    Private practice of David Plotsky, MD

    Washington D.C., District of Columbia, United States

    3

    Retina Group of Washington

    Washington D.C., District of Columbia, United States

    4

    Bascom Palmer Eye Institute, University of Miami School of Medicine

    Miami, Florida, United States